🔎 Trials Near Me

Domov › Debelost › Wisconsin

Klinične študije za Debelost v Wisconsin

11 študij za Debelost išče udeležence na lokacijah v Wisconsin.

Mesta v Wisconsin

Uradno besedilo študije (angleško)

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

  • Prevea Health, Green Bay
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT07564414

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Wisconsin Center for Advanced Research, Milwaukee
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Wisconsin Center for Advanced Research, Milwaukee
Vključevanje udeležencevFaza 3
Starost 18–70 · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06937086

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Aspirus Cardiovascular Associates, Wausau
Vključevanje udeležencevFaza 3
Starost 45–99 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07037433

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Advocate Aurora Saint Lukes Medical Center, Milwaukee
Vključevanje udeležencevFaza 3
Starost 18–99 · Vsi spoli · Posodobljeno 16. sep. 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Ascension Columbia St. Mary's, Milwaukee
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 14. sep. 2026 · NCT07351045

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Allegiance Research Specialists, Wauwatosa
Vključevanje udeležencevFaza 3
Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07684235

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Marshfield Clinic, Marshfield
  • Aurora St. Luke's Medi Ctr, Milwaukee
  • Cardio Research & Education Foundation, Wausau
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT07567001

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT06106477

Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity

  • Advocate Aurora Research Institute, Milwaukee
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 18 in več · Vsi spoli · Posodobljeno 24. jun. 2026 · NCT07227051

Stand up for Your Health With a Sit-stand Desk

  • Medical College of Wisconsin, Milwaukee
Vključevanje udeležencev
Starost 18–79 · Vsi spoli · Posodobljeno 4. maj 2026 · NCT05585190

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.